Condition: Infratentorial Neoplasms · Mutism · Sponsor: Rigshospitalet, Denmark
The purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.
This description comes directly from the study's public registry record.
Aske F Laustsen, MD, PhD stud · +45 40218998 · aske.foldbjerg.laustsen@regionh.dk
Astrid M Sehested, MD · +45 35451367 · astrid.marie.sehested@regionh.dk
Always discuss trial participation with your own doctor first.
| Medical University of Vienna | Vienna, Austria | Recruiting |
| University Hospital Leuven | Leuven, Belgium | Recruiting |
| Motol University Hospital | Prague, Czechia | Recruiting |
| Aalborg University Hospital | Aalborg, Denmark | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Odense University Hospital | Odense, Denmark | Recruiting |
| Helsinki University Central Hospital | Helsinki, Finland | Recruiting |
| Kuopio University Hospital | Kuopio, Finland | Not Yet Recruiting |
| Oulu University Hospital | Oulu, Finland | Not Yet Recruiting |
| Tampere University Hospital | Tampere, Finland | Not Yet Recruiting |
| Turku University Hospital | Turku, Finland | Not Yet Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02300766